logo
biểu ngữ biểu ngữ

Tin tức chi tiết

Nhà > Tin tức >

Tin tức về công ty A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China

Các sự kiện
Liên hệ với chúng tôi
Ms. Haileeping
86-0554-2796186
Liên hệ ngay bây giờ

A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China

2026-06-23
The 24th CPHI China 2026 was grandly held at Shanghai New International Expo Centre from June 16 to 18, 2026. As an immensely influential annual grand event for the global pharmaceutical industry, this exhibition brought together over 3,700 exhibitors from across the world.
Anhui Sunhere Pharmaceutical Excipients Co., Ltd. made a splendid appearance at Booth C46, Hall E3 with its core products and innovative technologies. Centered on the core theme of "Import Substitution", Sunhere Excipients demonstrated its robust strength to the global pharmaceutical sector in breaking foreign monopolies and achieving independent controllability of key pharmaceutical excipients.
tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  0
During this exhibition, Sunhere Excipients showcased a lineup of compound excipients as key highlights, including co-processed microcrystalline cellulose and colloidal silicon dioxide, co-processed microcrystalline cellulose and sodium carboxymethyl cellulose, lactose-povidone blends, and direct-compression premixed excipients featuring crospovidone.
Boasting unique functional merits, compound excipients have emerged as a focal point of attention among pharmaceutical formulation manufacturers at home and abroad. Unlike conventional premixed excipients produced via simple physical blending, compound excipients cannot be manufactured through mere mixing, featuring higher technical barriers and superior functional performance.
For a long time, imported compound excipients have dominated the high-end formulation market. Through sustained technological research and breakthroughs, Sunhere Excipients has become the first domestic enterprise to obtain both Chinese and US official registration approvals for co-processed microcrystalline cellulose and colloidal silicon dioxide, with both registrations fully activated. This milestone signifies that domestically produced compound excipients have reached a standard comparable to international brands in terms of product quality and regulatory compliance.
tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  1
During the exhibition, the international sales and technical service team of Sunhere Excipients conducted in-depth technical exchanges and business negotiations with pharmaceutical enterprises from Europe, America, India, Southeast Asia, the Middle East and other regions.
                       tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  2tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  3
                       tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  4tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  5

Targeting pain points in excipient application for novel formulation development, the team delivered customized technical solutions, fully demonstrating its one-stop service capacity.
Beyond business matching at the booth, senior experts from Sunhere Excipients including Chief Engineer Mr. Bi and R&D Director Li Xiangxiang were invited to take part in high-end industry forums such as the Seminar on International Regulations and Technological Development of Pharmaceutical Excipients and the International Salon for Pharmaceutical Excipients during the exhibition, where they shared the company’s latest R&D achievements.

This not only highlights Sunhere Excipients’ profound accumulation in excipient application technologies, but also embodies the enterprise’s sense of responsibility to actively engage in dialogues on international standards and advance high-quality development of the industry.
                        
                           tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  6tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  7
CPHI China serves not only as a platform to showcase brand competitiveness, but also as a core hub connecting the global pharmaceutical supply chain. Leveraging this high-standard exhibition platform, Sunhere Excipients has successfully accomplished the transition from product export to the internationalization of its technology and brand.
Moving forward, Sunhere Excipients will continue to adhere to an innovation-driven development strategy and its globalization roadmap, further expanding overseas markets. Meanwhile, it will keep pace with the demand for high-end excipients from biopharmaceuticals and complex formulations, delivering safer and more efficient excipient solutions to customers. Through independent innovation, the company will consolidate the security barrier of China’s pharmaceutical industrial supply chain.
biểu ngữ
Tin tức chi tiết
Nhà > Tin tức >

Tin tức về công ty-A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China

A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China

2026-06-23
The 24th CPHI China 2026 was grandly held at Shanghai New International Expo Centre from June 16 to 18, 2026. As an immensely influential annual grand event for the global pharmaceutical industry, this exhibition brought together over 3,700 exhibitors from across the world.
Anhui Sunhere Pharmaceutical Excipients Co., Ltd. made a splendid appearance at Booth C46, Hall E3 with its core products and innovative technologies. Centered on the core theme of "Import Substitution", Sunhere Excipients demonstrated its robust strength to the global pharmaceutical sector in breaking foreign monopolies and achieving independent controllability of key pharmaceutical excipients.
tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  0
During this exhibition, Sunhere Excipients showcased a lineup of compound excipients as key highlights, including co-processed microcrystalline cellulose and colloidal silicon dioxide, co-processed microcrystalline cellulose and sodium carboxymethyl cellulose, lactose-povidone blends, and direct-compression premixed excipients featuring crospovidone.
Boasting unique functional merits, compound excipients have emerged as a focal point of attention among pharmaceutical formulation manufacturers at home and abroad. Unlike conventional premixed excipients produced via simple physical blending, compound excipients cannot be manufactured through mere mixing, featuring higher technical barriers and superior functional performance.
For a long time, imported compound excipients have dominated the high-end formulation market. Through sustained technological research and breakthroughs, Sunhere Excipients has become the first domestic enterprise to obtain both Chinese and US official registration approvals for co-processed microcrystalline cellulose and colloidal silicon dioxide, with both registrations fully activated. This milestone signifies that domestically produced compound excipients have reached a standard comparable to international brands in terms of product quality and regulatory compliance.
tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  1
During the exhibition, the international sales and technical service team of Sunhere Excipients conducted in-depth technical exchanges and business negotiations with pharmaceutical enterprises from Europe, America, India, Southeast Asia, the Middle East and other regions.
                       tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  2tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  3
                       tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  4tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  5

Targeting pain points in excipient application for novel formulation development, the team delivered customized technical solutions, fully demonstrating its one-stop service capacity.
Beyond business matching at the booth, senior experts from Sunhere Excipients including Chief Engineer Mr. Bi and R&D Director Li Xiangxiang were invited to take part in high-end industry forums such as the Seminar on International Regulations and Technological Development of Pharmaceutical Excipients and the International Salon for Pharmaceutical Excipients during the exhibition, where they shared the company’s latest R&D achievements.

This not only highlights Sunhere Excipients’ profound accumulation in excipient application technologies, but also embodies the enterprise’s sense of responsibility to actively engage in dialogues on international standards and advance high-quality development of the industry.
                        
                           tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  6tin tức mới nhất của công ty về A Perfect Conclusion! Anhui Shanhe Pharmaceutical Excipients Co., Ltd. Returns with Full Honors from Its 2026 CPHI China  7
CPHI China serves not only as a platform to showcase brand competitiveness, but also as a core hub connecting the global pharmaceutical supply chain. Leveraging this high-standard exhibition platform, Sunhere Excipients has successfully accomplished the transition from product export to the internationalization of its technology and brand.
Moving forward, Sunhere Excipients will continue to adhere to an innovation-driven development strategy and its globalization roadmap, further expanding overseas markets. Meanwhile, it will keep pace with the demand for high-end excipients from biopharmaceuticals and complex formulations, delivering safer and more efficient excipient solutions to customers. Through independent innovation, the company will consolidate the security barrier of China’s pharmaceutical industrial supply chain.